Drug lookup
Drug reference

isoproterenol

Potent nonselective β adrenergic receptor agonist · Cardiostimulant, Bronchodilator

Potent nonselective β adrenergic receptor agonistCardiostimulant, BronchodilatorATC C01CA02
CDSCO approvedATC C01CA02
EXCRETION
not curated
INTERACTIONS
none in our sources
PREGNANCY
not curated

Mechanism

Isoproterenol is a potent nonselective β adrenergic receptor agonist with very low affinity for α receptors. It lowers peripheral vascular resistance, decreases diastolic pressure, and increases cardiac output due to positive inotropic and chronotropic effects. It relaxes almost all varieties of smooth muscle, notably bronchial and GI smooth muscle, preventing bronchoconstriction.

Indications

stimulate heart rate in patients with bradycardia or heart block (emergencies)ventricular arrhythmia torsades de pointes (emergencies)asthma (largely replaced by other drugs)shock (largely replaced by other drugs)Bronchodilation (as last resort)

Pharmacokinetics

Protein binding
duration of action longer than epinephrine but still relatively brief
Metabolism
metabolized by COMT, primarily in the liver (poor substrate for MAO and NET)

Contraindications

  • patients with coronary artery disease (cardiac ischemia)

Side effects

Common
palpitationstachycardiaheadacheflushing
Serious
  • arrhythmias
  • myocardial cell death (large doses in experimental animals)

Related guidelines

Ask House about isoproterenol

Continue into a citation-backed clinical answer with the drug context already attached.

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team